Posted on the MS Trust wesbsite
Source Lancet Neurology
An editorial in the latest issue of Lancet Neurology discusses the potential for vitamin D supplements to reduce the risk of developing multiple sclerosis.
The article concludes that trials are needed to address the many uncertainties that remain. Because any benefits for MS could take decades to emerge, a long-term outlook is needed from policy makers.http://www.mstrust.org.uk/news/article.jsp?id=3765